| SRP19 — Signal Recognition Particle 19 | |
|---|---|
| Symbol | SRP19 |
| Full Name | Signal Recognition Particle 19 |
| Chromosome | 19q13.2 |
| NCBI Gene | 6727 |
| Ensembl | ENSG00000131979 |
| OMIM | 607153 |
| UniProt | P49411 |
| Diseases | Alzheimer's Disease, Parkinson's Disease, Amyotrophic Lateral Sclerosis |
| Expression | Cerebral cortex, Hippocampus, Cerebellum, Spinal cord |
Srp19 Signal Recognition Particle 19 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
SRP19 (Signal Recognition Particle 19) is a gene located on chromosome 19q13.2 that encodes a protein component of the signal recognition particle (SRP), a ribonucleoprotein complex essential for targeting secretory and membrane proteins to the endoplasmic reticulum (ER) [1]. The SRP19 protein plays a critical role in the SRP cycle, which is fundamental to proper protein folding, processing, and quality control in eukaryotic cells.
SRP19 is a small protein (approximately 19 kDa) that serves as a key structural component of the SRP. The SRP particle recognizes signal sequences at the N-terminus of nascent polypeptides as they emerge from the ribosome. SRP19, together with SRP54 (the signal sequence binding subunit), forms the core of the SRP that mediates this recognition [2].
The SRP19 protein performs several essential functions:
SRP19 is expressed in all tissues, including the brain. In neurons, SRP-mediated protein targeting is crucial for:
Dysregulation of the SRP and the secretory pathway has been implicated in several neurodegenerative diseases:
Alzheimer's Disease: Impaired ER protein targeting and trafficking contribute to amyloid precursor protein (APP) processing and amyloid-beta production. The SRP machinery is involved in the proper folding and trafficking of APP and its processing enzymes [3].
Parkinson's Disease: Studies have shown that SRP components may be affected in PD models, potentially impacting protein quality control systems that are already compromised in PD pathogenesis [4].
Amyotrophic Lateral Sclerosis (ALS): Mutations in genes affecting the secretory pathway and ER stress response are associated with ALS. SRP function is critical for managing ER stress, which is a key pathological feature in ALS [5].
Huntington's Disease: The SRP machinery may be affected in HD, contributing to the accumulation of mutant huntingtin protein and impaired cellular proteostasis [6].
In neurodegeneration, several mechanisms may lead to SRP19 dysfunction:
Targeting the SRP pathway and the secretory pathway represents a potential therapeutic approach for neurodegenerative diseases. Strategies include:
The study of Srp19 Signal Recognition Particle 19 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.